SynthesisFrontiers in oncology2022

Predictive Efficacy of Blood-Based Tumor Mutation Burden Assay for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Nan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.